Discover
STOK
Stoke Therapeutics, Inc.
28.81
1 x 28.23
1 x 29.38
bid
ask
+
1.13
4.08%
04:00 PM
| Ytd | -9.23% | |
| 1y | 134.04% |
27.23
day range
29.05
12.25
52 week range
40.22
| Open | 27.66 | Prev Close | 27.68 | Low | 27.23 | High | 29.05 | Mkt Cap | 1.79B |
| Vol | 537.62K | Avg Vol | 705.00K | EPS | -2.81 | P/E | -10.25 | Forward P/E | 204.08 |
| Beta | 1.17 | Short Ratio | 14.73 | Inst. Own | 120.21% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 30.61 | 200-d Avg | 31.61 | 1yr Est | 45.82 |
| Income Statement | |||
| Total Revenue | 6.23M | ||
| Revenues (USD) | 6.23M | ||
| Gross Profit | 6.23M | ||
| Operating Expenses | 59.65M | ||
| Research and Development Expense | 39.67M | ||
| Selling, General and Administrative Expense | 19.97M | ||
| Operating Income | -53.42M | ||
| Interest Expense | -3.40M | ||
| Net Income | -50.00M | ||
| Net Income Common Stock | -50.00M | ||
| Net Income Common Stock (USD) | -50.00M | ||
| Consolidated Income | -50.00M | ||
| Earnings per Basic Share | -0.79 | ||
| Earnings per Basic Share (USD) | -0.79 | ||
| Earnings per Diluted Share | -0.79 | ||
| Earning Before Interest & Taxes (EBIT) | -53.40M | ||
| Earning Before Interest & Taxes (USD) | -53.40M | ||
| Weighted Average Shares | 63.06M | ||
| Weighted Average Shares Diluted | 63.06M | ||
| Balance Sheet | |||
| Cash and Equivalents | 155.66M | ||
| Cash and Equivalents (USD) | 155.66M | ||
| Investments | 258.59M | ||
| Investments Current | 187.89M | ||
| Investments Non-Current | 70.71M | ||
| Trade and Non-Trade Receivables | 4.45M | ||
| Current Assets | 366.68M | ||
| Property, Plant & Equipment Net | 5.89M | ||
| Total Assets | 443.28M | ||
| Current Liabilities | 40.81M | ||
| Total Liabilities | 48.40M | ||
| Accumulated Retained Earnings (Deficit) | -547.72M | ||
| Accumulated Other Comprehensive Income | -115.00K | ||
| Shareholders Equity | 394.88M | ||
| Shareholders Equity (USD) | 394.88M | ||
| Assets Non-Current | 76.60M | ||
| Deferred Revenue | 16.67M | ||
| Liabilities Non-Current | 7.59M | ||
| Trade and Non-Trade Payables | 6.84M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.05M | ||
| Net Cash Flow from Financing | 84.33M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 74.44M | ||
| Capital Expenditure | -353.00K | ||
| Issuance (Purchase) of Equity Shares | 84.33M | ||
| Net Cash Flow from Investing | 50.69M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 51.05M | ||
| Net Cash Flow from Operations | -60.58M | ||
| Share Based Compensation | 8.75M | ||